GURU.Markets stock price, segment price, and overall market index valuation
The company's share price POAI
Predictive Oncology uses AI to develop personalized cancer treatments. Its stock price is a venture bet on the success of its platform. The stock price reflects high volatility, dependent on development news and partnerships with pharmaceutical companies.
Share prices of companies in the market segment - Medical instruments
Predictive Oncology uses artificial intelligence to analyze tumors and predict the most effective cancer treatments. We've categorized it as a "Medical Tools" company. The chart below shows how the market values companies at the intersection of AI, oncology, and personalized medicine.
Broad Market Index - GURU.Markets
Predictive Oncology uses artificial intelligence to analyze tumors and predict the most effective cancer treatments. Its innovative approach makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Predictive Oncology compares to it.
Change in the price of a company, segment, and market as a whole per day
POAI - Daily change in the company's share price POAI
Predictive Oncology Inc.'s daily stock price fluctuations reflect the high volatility of the biotech and AI space. This metric measures the company's sensitivity to news about the use of its drug discovery platform.
Daily change in the price of a set of shares in a market segment - Medical instruments
Predictive Oncology uses AI for drug development, placing it at the intersection of biotech and AI—two volatile sectors. The chart below shows the average daily price fluctuations for this industry. It serves as a benchmark for understanding the risk and potential of POAI stock compared to its peers.
Daily change in the price of a broad market stock, index - GURU.Markets
Predictive Oncology uses artificial intelligence to predict the effectiveness of cancer drugs. The company is located at the intersection of two hot sectors—AI and biotech. This creates high volatility, which contributes to overall market dynamics.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization POAI
For Predictive Oncology, year-over-year performance is a story about the application of AI in personalized medicine. Its market cap growth over the past 12 months reflects demand for its platform, which uses AI to predict tumor responses to various drugs, helping pharmaceutical companies speed up and reduce the cost of clinical trials.
Annual dynamics of market capitalization of the market segment - Medical instruments
Predictive Oncology Inc. uses AI to personalize cancer treatment. Its platform helps predict tumor response to drugs. The chart shows how the market views its innovative but capital-intensive technology and its path to commercialization compared to traditional biotech.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Predictive Oncology is trying to revolutionize drug development using AI. Its performance relative to the market tells a story about whether investors believe in its breakthrough technology. Outperforming growth will mean market recognition and partnerships with major pharma companies.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization POAI
Predictive Oncology uses AI for personalized oncology. Its monthly growth depends on signing contracts with pharmaceutical companies to use its platform. News of partnerships and validation of its approach are key drivers.
Monthly dynamics of market capitalization of the market segment - Medical instruments
Predictive Oncology uses artificial intelligence and its biodatabase to predict the effectiveness of cancer drugs, assisting pharmaceutical companies in their drug development. The chart below shows the dynamics of the medical device sector, where AI is becoming a key tool for personalized medicine.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Predictive Oncology uses AI for personalized cancer treatment. Its stock is a biotech-AI hybrid, highly volatile, and loosely tied to the market. The chart will show price movements driven by news of technological breakthroughs and partnerships, rather than by overall stock market sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization POAI
Predictive Oncology uses AI to predict responses to cancer treatment. Its weekly stock price is a speculative bet on a revolution in personalized medicine, with partnership news a key driver.
Weekly dynamics of market capitalization of the market segment - Medical instruments
Predictive Oncology uses AI to personalize cancer treatment. The chart compares the weekly performance of this medtech company with its sector. Is it outperforming the industry thanks to its technology, or is its stock moving in the mainstream of companies working at the intersection of AI and medicine?
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Predictive Oncology, as a healthcare technology company, sits at the intersection of the defensive medical sector and the volatile tech sector. The chart will reveal which of these forces dominates. Is it moving like a stable medical company or a risky tech startup?
Market capitalization of the company, segment and market as a whole
POAI - Market capitalization of the company POAI
The Predictive Oncology chart shows a bet on the application of AI in personalized medicine. Its market cap reflects investors' belief that the company's platform can predict tumor response to various drugs, potentially making cancer treatment more effective.
POAI - Share of the company's market capitalization POAI within the market segment - Medical instruments
Predictive Oncology uses artificial intelligence to analyze tumors and predict the most effective cancer treatments. Its market share in the medical instruments and diagnostics segment reflects its cutting-edge technological approach. The company's size reflects its bet that AI-based personalized oncology will become the new standard in cancer treatment.
Market capitalization of the market segment - Medical instruments
Predictive Oncology uses AI to personalize cancer treatment. How big is this revolution? The chart below shows the overall market capitalization of the medical instruments sector. Its dynamics reflect how artificial intelligence is becoming a key tool in the fight against cancer, helping to select the right drug for the right patient.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Predictive Oncology chart shows how the market is valuing the use of AI to personalize cancer treatment. The company's market cap is based on its platform, which predicts tumor response to various drugs. This diagram illustrates how technology is trying to make oncology more accurate.
Book value capitalization of the company, segment and market as a whole
POAI - Book value capitalization of the company POAI
The book value of Predictive Oncology, which uses AI to predict drug response, is derived from its tangible assets: laboratories, a tumor tissue biobank, and powerful computing infrastructure. The chart below shows how the company has invested in creating this unique scientific platform.
POAI - Share of the company's book capitalization POAI within the market segment - Medical instruments
Predictive Oncology Inc. uses AI for personalized medicine. Its unique assets include not only computing power but also laboratories with robotic systems for drug testing of tumors. The graph shows what share of this hybrid infrastructure, from test tube to server, the company controls.
Market segment balance sheet capitalization - Medical instruments
Predictive Oncology is an IT company for healthcare. Compared to the capital-intensive sector, it's asset-light. The industry's asset chart reflects the value of laboratories. Predictive, on the other hand, uses AI to analyze data; its capital is its algorithms.
Book value of all companies included in the broad market index - GURU.Markets
Predictive Oncology's assets are not drugs, but a unique AI platform and laboratory that helps predict which drug will be most effective for a specific tumor. Its book value reflects its technological foundation for personalized oncology.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - POAI
Predictive Oncology uses AI to predict tumor response to drugs. Its value lies in its platform. The chart shows how the market values its ability to help pharmaceutical companies develop drugs more efficiently.
Market to book capitalization ratio in a market segment - Medical instruments
Predictive Oncology uses AI to predict responses to cancer treatment, helping develop new drugs. Its value lies in its platform and data. The chart shows the market premium for its technology, which can speed up and reduce the cost of drug development.
Market to book capitalization ratio for the market as a whole
Predictive Oncology uses AI to select cancer treatments. Algorithms and accumulated data are its main assets, not servers. This chart shows the enormous premium the market places on companies applying cutting-edge technologies to personalized medicine, seeing it as the future of healthcare.
Debts of the company, segment and market as a whole
POAI - Company debts POAI
Predictive Oncology uses artificial intelligence to predict responses to cancer treatment, helping pharmaceutical companies develop drugs. For such a science-intensive IT company, capital is essential for R&D, access to computing power, and hiring specialists. This chart shows how the company funds its cutting-edge, yet expensive, research.
Market segment debts - Medical instruments
Predictive Oncology uses artificial intelligence to develop personalized cancer therapies. Like other biotech startups, it invests in its platform and team. This chart shows how it funds its research, which straddles the intersection of biology and computer science.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio POAI
Predictive Oncology uses AI to develop cancer drugs. This chart shows the financial structure of a high-tech company at the intersection of IT and biotech. Debt at a stage when the technology is not yet generating stable revenue is a high-risk factor, limiting research flexibility.
Market segment debt to market segment book capitalization - Medical instruments
Predictive Oncology uses artificial intelligence to predict tumor responses to various drugs, helping personalize cancer treatment. This chart shows the sector's overall debt load, helping to understand how the company finances its expensive computing platforms and research in this cutting-edge field.
Debt to book value of all companies in the market
Predictive Oncology uses AI to develop personalized cancer treatments. It's an IT company serving a knowledge-intensive industry. This chart, showing the debt of the traditional economy, highlights that the company's financial model is based on technology rather than physical assets, making it less reliant on debt financing.
P/E of the company, segment and market as a whole
P/E - POAI
This chart for Predictive Oncology, a medical company using AI to select cancer treatments, shows a speculative valuation. A price-to-earnings ratio is not applicable here. This is a bet that its technology platform will truly improve the efficiency of drug development and become in demand by pharmaceutical companies.
P/E of the market segment - Medical instruments
Predictive Oncology uses artificial intelligence and its extensive biodatabase to predict tumor responses to various treatments, assisting pharmaceutical companies in drug development. This chart shows the average rating for the sector, helping to understand how the market values this cutting-edge personalized oncology platform.
P/E of the market as a whole
Predictive Oncology uses AI to predict how cancer tumors respond to various drugs, helping pharmaceutical companies develop drugs. Its valuation is a bet on its technology platform. It's not tied to the general economic cycles shown in this chart, but depends on its ability to prove the effectiveness of its approach.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company POAI
Predictive Oncology uses artificial intelligence to analyze tumors and predict their response to various treatments, assisting pharmaceutical companies in drug development. This graph reflects expectations for AI adoption in oncology. Future revenue depends on contracts with pharmaceutical companies and the success of its platform.
%20P%2FE%20POAI&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-POAI&v=1772560069477 "Chart of the company's future (projected) P/E POAI")
Future (projected) P/E of the market segment - Medical instruments
Predictive Oncology uses artificial intelligence to predict tumor responses to various treatments, aiding drug development. Its valuation relative to other biotech and healthcare IT companies reflects investors' faith in its unique platform, betting that its AI can make cancer research more accurate and faster.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medical-instruments&v=1772560069491 "Future (projected) P/E graph of the market segment - Medical instruments")
Future (projected) P/E of the market as a whole
Predictive Oncology uses artificial intelligence to predict tumor responses to various drugs, helping pharmaceutical companies develop new treatments. It's a service company for the pharmaceutical industry. This chart reflects the overall sentiment in the biotech sector, demonstrating the willingness of investors and pharmaceutical companies to invest in innovative R&D platforms.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772560069504 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit POAI
Predictive Oncology uses artificial intelligence and its tumor biobank to predict cancer response to various treatments, assisting pharmaceutical companies in drug development. Financial results shown here are dependent on contract awards with pharmaceutical industry players.
Profit of companies in the market segment - Medical instruments
Predictive Oncology uses AI to predict tumor responses to various drugs, helping develop personalized therapies. This chart shows the combined profitability of the medical devices and IT sector. It demonstrates how much the pharmaceutical industry is willing to pay for technologies that can improve the chances of clinical trial success.
Overall market profit
Predictive Oncology uses AI to predict the effectiveness of cancer drugs. It's a technology platform designed to accelerate drug development. Its success depends on the accuracy of its models and successful contracts with pharmaceutical companies. This schedule is important for R&D budgets, but POAI technology is the main driver.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company POAI
Predictive Oncology uses artificial intelligence to predict the effectiveness of cancer treatments, assisting pharmaceutical companies in drug development. Future revenue depends on contracts with the pharmaceutical industry. This chart reflects analysts' expectations for demand for its AI platform for personalized medicine.
%20profit%20of%20the%20company%20POAI&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-POAI&v=1772560069571 "Graph of future (projected) profit of the company POAI")
Future (predicted) profit of companies in the market segment - Medical instruments
Predictive Oncology uses artificial intelligence and biosimulation to analyze tumors and predict the most effective cancer treatments for individual patients. This chart shows forecasts for the medical devices sector. It illustrates how personalized medicine and AI can revolutionize oncology, increasing treatment effectiveness and reducing costs.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medical-instruments&v=1772560069586 "Graph of future (predicted) profits of companies in a market segment - Medical instruments")
Future (predicted) profit of the market as a whole
This chart illustrates pharmaceutical companies' R&D budgets. Predictive Oncology, which uses AI for drug development, relies on these expenses. Economic growth allows pharma giants to invest more in innovative approaches, increasing demand for their services. A recession forces them to cut R&D budgets.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772560069613 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - POAI
Predictive Oncology uses AI to predict the effectiveness of cancer drugs. This metric reflects investors' confidence in its technology. It estimates potential revenue from partnerships with pharmaceutical companies, not current sales.
P/S market segment - Medical instruments
Predictive Oncology uses artificial intelligence to predict tumor responses to various treatments, assisting pharmaceutical companies in drug development. This chart shows the average valuation in the medical instruments and AI sector. It reflects investor confidence in the potential of AI to personalize cancer treatment.
P/S of the market as a whole
Predictive Oncology Inc. uses artificial intelligence to analyze tumors and predict the most effective cancer treatments. It's a service model for pharmaceutical companies. Future revenue depends on the adoption of its platform. This chart helps assess how the market values AI "tool" companies in oncology.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company POAI
Predictive Oncology uses AI to predict tumor responses to various treatments, aiding drug development. Future revenue depends on contracts with pharmaceutical companies. The chart demonstrates investors' confidence that its platform will become a key tool for personalized oncology.
%20P%2FS%20POAI&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-POAI&v=1772560069796 "The graph of the company's future (projected) P/S POAI")
Future (projected) P/S of the market segment - Medical instruments
Predictive Oncology uses artificial intelligence and its extensive biodatabase to predict the effectiveness of cancer drugs, helping pharmaceutical companies optimize their development. This chart shows how the market evaluates the commercial potential of its unique predictive platform compared to other medical tools.
%20P%2FS%20market%20segment%20graph%20-%20Medical%20instruments&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medical-instruments&v=1772560069810 "Future (projected) P/S market segment graph - Medical instruments")
Future (projected) P/S of the market as a whole
This chart illustrates investor sentiment in the field of personalized oncology. For Predictive Oncology, a company using AI to select treatments, it's a trend indicator. Market optimism is fueled by the shift toward medicine where treatments are individually tailored based on tumor analysis, which is the essence of the company's technology.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772560069845 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales POAI
Predictive Oncology uses artificial intelligence and its tumor biobank to predict patient responses to various cancer drugs, assisting pharmaceutical companies in drug development. This chart shows revenue from these predictive services. Revenue growth will signal recognition of the value of their personalized medicine platform.
Sales of companies in the market segment - Medical instruments
Predictive Oncology uses artificial intelligence to analyze tumors and predict the most effective cancer treatments. This graph shows the growth of the medical instruments and diagnostics market. The company's platform helps personalize therapy, one of the most important trends in modern oncology and driving the entire industry forward.
Overall market sales
Predictive Oncology uses artificial intelligence to predict responses to cancer treatment, helping pharmaceutical companies develop drugs. Demand for its platform depends on R&D budgets. This overall economic activity influences the pharmaceutical industry's willingness to invest in cutting-edge technologies to improve the efficiency of its research.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company POAI
Predictive Oncology uses artificial intelligence to analyze tumors and predict responses to various treatments, assisting pharmaceutical companies in drug development. This chart reflects analysts' expectations for the growth of the AI market in oncology and the company's ability to secure contracts with the pharmaceutical industry.
%20sales%20of%20the%20company%20POAI&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-POAI&v=1772560069903 "Schedule of future (projected) sales of the company POAI")
Future (projected) sales of companies in the market segment - Medical instruments
Predictive Oncology uses artificial intelligence to predict tumor response to various treatments. This chart shows expectations for the medical instruments and technologies sector. It reflects the growing trend toward personalized medicine, where AI technologies are playing an increasingly important role.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medical-instruments&v=1772560069919 "Schedule of future (projected) sales of companies in the market segment - Medical instruments")
Future (projected) sales of the market as a whole
Predictive Oncology Inc. uses artificial intelligence and biosimulation to predict tumor responses to various therapies, assisting pharmaceutical companies in drug development. Demand for its services depends on oncology R&D budgets. This dynamic, reflecting the overall economic climate, influences the funding pharma companies are willing to invest in innovative tools.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772560069931 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality POAI
Predictive Oncology uses AI to predict tumor responses to various drugs, helping develop personalized therapies. The graph shows the financial status of this technology at the commercialization stage. Future profits depend on contracts with pharmaceutical companies, which it helps improve the success of clinical trials.
Market segment marginality - Medical instruments
Predictive Oncology uses artificial intelligence to predict tumor responses to various treatments, helping develop personalized drugs. The profitability of this model depends on the accuracy of its platform and partnerships with pharmaceutical companies. The graph shows the average profitability in the sector, assessing the commercial potential of their technology.
Market marginality as a whole
Predictive Oncology uses artificial intelligence to predict tumor responses to various treatments, helping pharmaceutical companies develop drugs. This overall market profitability indirectly impacts R&D budgets. However, the company is more concerned with proving the value of its platform, which could save billions of dollars by making drug development more predictable.
Employees in the company, segment and market as a whole
Number of employees in the company POAI
Predictive Oncology uses an AI platform to predict tumor responses to various drugs, aiding in the development of personalized therapies. This graph shows the team of biologists, data scientists, and AI specialists. Their number reflects the complexity and science-intensive nature of their approach.
Share of the company's employees POAI within the market segment - Medical instruments
Predictive Oncology uses AI to predict tumor responses to various drugs, personalizing cancer treatment. This chart shows the percentage of bioinformaticians, machine learning specialists, and oncologists working at the intersection of IT and medicine that the company employs. It reflects its concentration of unique talent to shape the medicine of the future.
Number of employees in the market segment - Medical instruments
Predictive Oncology uses artificial intelligence to analyze tumors and select the most effective therapy for individual patients. Personalized oncology is the future. This graph illustrates how the confluence of AI and medicine is creating new treatment approaches and requires a new type of specialist—bioinformaticians who can "speak the language" of both doctors and programmers.
Number of employees in the market as a whole
Predictive Oncology uses AI to personalize cancer treatment. This fusion of technology and medicine is a key trend. This graph reflects the current employment structure, but it is companies like POAI that are creating entirely new professions at the intersection of oncology, genetics, and big data analysis, shaping the medicine of the future.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company POAI (POAI)
Predictive Oncology uses AI and a biobank to predict cancer treatment response. This chart represents the company's net intellectual capital. The company's assets are its AI platform (PEDAL) and a massive sample bank. The chart shows how highly the market values this unique combination of data and technology, which can accelerate drug development, per employee.
%20of%20the%20company%20POAI%20(POAI)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-POAI-POAI&v=1772560070086 "Chart of market capitalization per employee (in thousands of dollars) of the company POAI (POAI)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
Predictive Oncology uses AI to predict cancer treatment outcomes, helping pharmaceutical companies develop drugs. The company's value lies in its unique platform and team of data scientists. The chart shows the premium the market pays for this intellectual capital, reflecting the potential of their technology.
%20by%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medical-instruments&v=1772560070095 "Market capitalization per employee (in thousands of dollars) by market segment - Medical instruments")
Market capitalization per employee (in thousands of dollars) for the overall market
Predictive Oncology uses artificial intelligence to develop personalized cancer treatments. This chart shows the average value the market places on a single employee, highlighting the enormous value of technologies at the intersection of AI and medicine.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772560070105 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company POAI (POAI)
Predictive Oncology uses AI for personalized cancer drug selection. It's an IT company at the intersection of biotech. This chart likely shows the company's per-employee cost. It reflects how much the company invests in each data scientist and engineer to build its analytics platform.
%20Chart%20POAI%20(POAI)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-POAI-POAI&v=1772560070107 "Company Profit Per Employee (in thousands of dollars) Chart POAI (POAI)")
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
Predictive Oncology uses artificial intelligence to develop personalized cancer treatments. It's an IT company at the intersection of biotech and data science. Its value lies in its unique platform and team of data scientists. This chart shows how the company monetizes its technology, and its potentially high profit per employee reflects the intellectual, rather than production, nature of its business.
%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medical-instruments&v=1772560070118 "Chart of profit per employee (in thousands of dollars) in the market segment - Medical instruments")
Profit per employee (in thousands of dollars) for the market as a whole
Predictive Oncology (POAI) uses an AI platform (PEDAL) to analyze tumors and predict which drugs will be most effective for a particular patient. They assist pharmaceutical companies in R&D. This is a B2B AI/MedTech business. This chart shows the market-standard profitability per employee. It helps assess how effective POAI's AI model (few people, high IP) can be in generating USD.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772560070178 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee POAI (POAI)
Predictive Oncology uses AI to aid in cancer drug development. This chart demonstrates the potential of AI and biotech convergence. It reflects the company's ability to market its unique services to pharmaceutical companies, where each data analysis project can generate significant revenue for its team of specialists.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-POAI-POAI&v=1772560070235 "Sales chart per company employee POAI (POAI)")
Sales per employee in the market segment - Medical instruments
Predictive Oncology uses AI and its biosimulation platform to predict drug responses, helping pharmaceutical companies in R&D. It's an IT-medtech company. This chart shows the average revenue per employee in the segment. It helps evaluate how effectively the POAI team monetizes its analytics platform compared to competitors.
Sales per employee for the market as a whole
Predictive Oncology uses AI and a tumor biobank to predict drug efficacy, helping pharmaceutical companies in R&D. It's a B2B service. This chart shows how productive their team of scientists and data analysts is, generating revenue from selling their unique predictive services.
Short shares by company, segment and market as a whole
Shares shorted by company POAI (POAI)
Predictive Oncology is a company that claims to use AI to predict the success of oncology drugs, helping biotech companies in R&D. This chart shows that investors don't believe in their AI platform. The bears are betting that their technology has no real predictive power and is simply hype without science.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-POAI-POAI&v=1772560070268 "Short Shares Chart for the Company POAI (POAI)")
Shares shorted by market segment - Medical instruments
Predictive Oncology uses AI and a biobank of tumor samples to predict patient responses to oncology drugs, helping pharmaceutical companies in R&D. This chart shows the overall short position in the medical instruments and diagnostics sector. Its rise reflects investor doubts that AI platforms can truly improve oncology R&D.
Shares shorted by the overall market
Predictive Oncology uses AI to predict tumor response to drugs, assisting biotechs in R&D. This chart measures overall fear. When investors are fearful, biotech companies (POAI clients) cut R&D budgets. They focus on lead drugs, postponing contracts for supporting AI platforms, which poses risks to Predictive Oncology's growth.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator POAI (POAI)
Predictive Oncology uses AI and its platform (PEDAL) to predict which drug will be most effective for a specific tumor. It's betting on the intersection of AI and biotech. This chart tracks the hype around AI in medicine, showing whether it's "overheated" (above 70) due to partnership news or "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-POAI-POAI&v=1772560070325 "RSI 14 indicator chart for the company's stock POAI (POAI)")
RSI 14 Market Segment - Medical instruments
Predictive Oncology uses AI and its platform (PeDAL) to analyze tumors and predict the most effective cancer treatments. This graph measures the collective excitement in the oncology biotech and AI sector. It helps determine whether the entire segment is overheated by expectations of breakthroughs in AI medicine.
RSI 14 for the overall market
For Predictive Oncology, a biotech company in R&D, this chart is a lifeline showing capital availability. During moments of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the money supply is shut off, and cash-burning companies face a liquidity crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast POAI (POAI)
Predictive Oncology uses an AI platform (PEDAL) to predict drug response, helping pharmaceutical companies develop oncology treatments. This chart shows the average analyst forecast. Their targets are based on the number of contracts signed with biotech companies, the success of their AI models, and revenue growth from data analytics services.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-POAI-POAI&v=1772560070375 "A chart showing analyst consensus forecasts for the expected stock price. POAI (POAI)")
The difference between the consensus estimate and the actual stock price POAI (POAI)
Predictive Oncology isn't a drugmaker, but a company that uses AI (the PEDAL platform) to predict which drugs will work for specific tumors. This chart shows how much the current stock price differs from the "fair" value predicted by analysts. It reflects their faith in this "predictive" AI platform.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-POAI-POAI&v=1772560070383 "A chart showing the difference between the consensus forecast and the actual stock price. POAI (POAI)")
Analyst consensus forecast for stock prices by market segment - Medical instruments
Predictive Oncology (POAI) uses AI (the PEDAL platform) to analyze tumors to predict which drugs will work. It's an R&D service for pharmaceutical companies. This chart shows general expectations for the medical devices sector. It reflects whether experts believe AI can truly speed up and reduce the cost of cancer drug development.
Analysts' consensus forecast for the overall market share price
Predictive Oncology (POAI) is an "oracle" for biotech. Their AI platform helps pharmaceutical companies predict which cancer drugs will work, saving millions on R&D. This chart shows the overall risk appetite. It reflects the level of confidence analysts have in the R&D budgets of "big pharma," a POAI client and the first to cut research spending during the crisis.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index POAI
Predictive Oncology is an AI-powered oncologist. Their signature feature is an R&D platform (PEDAL) that uses AI to predict (using tumor samples) which drugs will kill which cancers. They sell this service to biotech companies to save their R&D. This chart is a summary indicator of their AI model. It reflects their (slow) progress in commercializing this platform and their transition from hardware to data.
AKIMA Market Segment Index - Medical instruments
Predictive Oncology (POAI) uses AI to address the core challenge of biotech: prediction. Their PEDAL platform helps determine which drugs will work against specific tumors, reducing R&D risks. This chart shows the average index for the segment, allowing investors to gauge how much market expectations for POAI's AI platform are ahead of or behind the average.
The AKIM Index for the overall market
Predictive Oncology is a company using AI and tumor biobanks to improve cancer drug development. This chart, which reflects the market average, is just a backdrop. It helps assess how this pharma technology partner stacks up against overall macroeconomic trends.
